Does an animal tendon experiment answer the human recovery question?

No. An animal experiment can explore a mechanism under controlled conditions, but a person's injury, rehabilitation and outcome are different. The human claim needs relevant clinical evidence rather than a direct transfer from laboratory observations. [1, 3]

Does the FDA briefing say BPC-157 has never been used in humans?

No. The briefing discusses limited human reports and studies in other contexts. Its statement that no tendonitis clinical studies were identified should not be broadened into a claim that all human BPC-157 research is absent. [3]

What would a meaningful tendon study need to report?

Look for a defined injury and preparation, an appropriate comparison, follow-up, function or recovery outcomes, and harms. Improvement reported without those details cannot establish that the substance caused the change or that the result applies elsewhere.

Does a study registration count as a successful treatment trial?

No. Registration describes a study plan and may not contain results. Check whether findings were actually reported, which outcomes were measured and whether the record concerns tendon injuries rather than another condition or healthy volunteers.

Is BPC-157 proven to heal tendons in humans?

Sipra editorial team

Updated 2026-09-16

FDA’s July 2026 BPC-157 evaluation reported that it identified no clinical studies in tendonitis. Animal or laboratory findings do not establish that an injection will repair a person’s tendon. ^{1, 2, 3}

A useful tendon study would need a clearly identified product, a defined injury, an appropriate comparison, and outcomes such as function, recovery, and harms. Testimonials cannot answer those questions.

FDA describes limited safety information for BPC-157. Its July 2026 evaluation focused on ulcerative colitis; FDA did not evaluate tendonitis use because the nomination lacked sufficient information. This is not proof of tendon-healing benefit.

Why do animal studies get so much attention?

They can suggest biological mechanisms worth studying. Human tendon injuries differ in cause, severity, treatment, and rehabilitation, so a promising laboratory result is an early research signal.

What can I discuss with a clinician instead?

Ask about the diagnosis, whether imaging is useful, activity modification, rehabilitation, and the evidence for the treatments appropriate to that injury. A persistent injury deserves an assessment rather than a product promise.

Bottom line

A tendon-healing claim needs tendon-specific human evidence. BPC-157 does not yet have evidence that justifies treating such claims as established.

Explore peptide evidence and safety

Is BPC-157 proven to heal tendons in humans?

Why do animal studies get so much attention?

What can I discuss with a clinician instead?

Frequently asked questions

Related questions

Your Privacy Choices

Your Privacy Choices